BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28248800)

  • 1. Mixed Connective Tissue Disease and Epitope Spreading: An Historical Cohort Study.
    Escolà-Vergé L; Pinal-Fernandez I; Fernandez-Codina A; Callejas-Moraga EL; Espinosa J; Marin A; Labrador-Horrillo M; Selva-O'Callaghan A
    J Clin Rheumatol; 2017 Apr; 23(3):155-159. PubMed ID: 28248800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.
    Mesa A; Somarelli JA; Wu W; Martinez L; Blom MB; Greidinger EL; Herrera RJ
    Lupus; 2013 Nov; 22(13):1371-81. PubMed ID: 24158973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease.
    Ghirardello A; Doria A; Vesco P; Vaccaro E; Bernardi C; Catani C; Fagiolo U; Gambari PF
    Rheumatol Int; 1996; 16(4):145-50. PubMed ID: 8961378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody].
    Miyamae T; Ito S; Machida H; Ozawa R; Higuchi R; Nakajima S; Imagawa T; Nakamura T; Mori M; Aihara Y; Ohshige K; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):405-14. PubMed ID: 18974625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen.
    Greidinger EL; Zang Y; Jaimes K; Hogenmiller S; Nassiri M; Bejarano P; Barber GN; Hoffman RW
    Arthritis Rheum; 2006 Feb; 54(2):661-9. PubMed ID: 16453294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease.
    Hof D; Cheung K; de Rooij DJ; van den Hoogen FH; Pruijn GJ; van Venrooij WJ; Raats JM
    Arthritis Res Ther; 2005; 7(2):R302-9. PubMed ID: 15743477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed connective tissue disease.
    Gunnarsson R; Hetlevik SO; Lilleby V; Molberg Ø
    Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):95-111. PubMed ID: 27421219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.
    Somarelli JA; Mesa A; Rodriguez R; Avellan R; Martinez L; Zang YJ; Greidinger EL; Herrera RJ
    Lupus; 2011 Mar; 20(3):274-89. PubMed ID: 21362751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations and anti-(U1)snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients.
    Lundberg I; Nyman U; Pettersson I; Hedfors E
    Br J Rheumatol; 1992 Dec; 31(12):811-7. PubMed ID: 1458287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.
    Burdt MA; Hoffman RW; Deutscher SL; Wang GS; Johnson JC; Sharp GC
    Arthritis Rheum; 1999 May; 42(5):899-909. PubMed ID: 10323445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
    Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
    J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basophils and IgE contribute to mixed connective tissue disease development.
    Lamri Y; Vibhushan S; Pacreau E; Boedec E; Saidoune F; Mailleux A; Crestani B; Blank U; Benhamou M; Papo T; Daugas E; Sacré K; Charles N
    J Allergy Clin Immunol; 2021 Apr; 147(4):1478-1489.e11. PubMed ID: 33338538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies in the pathogenesis of mixed connective tissue disease.
    Greidinger EL; Hoffman RW
    Rheum Dis Clin North Am; 2005 Aug; 31(3):437-50, vi. PubMed ID: 16084317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse.
    Amigues JM; Cantagrel A; Abbal M; Mazieres B
    J Rheumatol; 1996 Dec; 23(12):2055-62. PubMed ID: 8970041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed connective tissue disease: overlap syndromes.
    Maddison PJ
    Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):111-24. PubMed ID: 10882217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does mixed connective tissue disease exist? Yes.
    Aringer M; Steiner G; Smolen JS
    Rheum Dis Clin North Am; 2005 Aug; 31(3):411-20, v. PubMed ID: 16084315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD).
    Okawa-Takatsuji M; Aotsuka S; Uwatoko S; Sumiya M; Yokohari R
    Clin Exp Immunol; 1994 Dec; 98(3):427-33. PubMed ID: 7994907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection.
    Newkirk MM; van Venrooij WJ; Marshall GS
    Arthritis Res; 2001; 3(4):253-8. PubMed ID: 11438044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome.
    Coppo P; Clauvel JP; Bengoufa D; Oksenhendler E; Lacroix C; Lassoued K
    Rheumatology (Oxford); 2002 Sep; 41(9):1040-6. PubMed ID: 12209039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of diagnostic criteria and new insights into clinical testing in mixed connective tissue disease; anti-survival motor neuron complex antibody as a novel marker of severity of the disease.
    Kubo S; Tanaka Y
    Immunol Med; 2024 Jun; 47(2):52-57. PubMed ID: 38597289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.